プラダー・ウィリー症候群 (PWS) 治療薬の世界市場：市場機会と将来予測
Global Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024)
|出版日||ページ情報||英文 120 Pages
|プラダー・ウィリー症候群 (PWS) 治療薬の世界市場：市場機会と将来予測 Global Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024)|
|出版日: 2019年09月30日||ページ情報: 英文 120 Pages||
当レポートでは、世界のプラダー・ウィリー症候群 (PWS) 治療薬の市場について分析し、疾患の概要や主な治療法、現在治験中の有望なパイプライン製品、有病者数および市場収益額の動向見通し (過去2年間・今後6年間分)、地域別の詳細動向、市場促進・抑制要因、市場の求心力、主要企業のプロファイルなどを調査しております。
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Prader-Willi Syndrome market. The report analyses the Global Prader-Willi Syndrome Therapeutics Market in terms of its sizing, growth and forecast. The report presents a comprehensive pipeline assessment that includes DCCR (Soleno Therapeutics), Levolitide (Millendo Therapeutics) and Tesomet (Saniona). Also, the report analyzes the prevalence of PWS and profiles the leading companies operating in the PWS Therapeutics market. The report analyzes the Global Market, European Region Market and the country analysis of United States and Japan for the historical period of 2017 and 2018 and the forecast period of 2019-2024.
According to Azoth Analytics research report, the Prader-Willi Syndrome therapeutics market is projected to display a robust growth represented by a CAGR of 4.6% during 2019 - 2024.
Over the recent years, the Prader-Willi Syndrome market has been witnessing considerable growth directly on the back of the increasing number of diagnosed patient's population. Moreover, growing human growth hormone therapy coverage rate, surging awareness and increasing government involvement have been driving the market.
Further, expected launch of novel therapies, such as DCCR (Soleno Therapeutics), Livoletide (Millendo Therapeutics), Testomet (Saniona AB) among others are anticipated to fuel the market growth.
The report titled report "Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024)" has covered and analyzed the potential of Prader-Willi Syndrome market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges, opportunities and market entry strategies for various companies. Additionally, the report also highlights the estimated prevalence of Prader-Willi Syndrome in USA, Europe and Japan.
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.